Preliminary Results Show AstraZeneca Vaccine Can Prevent COVID-19

AstraZeneca says a study of its vaccine showed an efficacy of 79% for preventing symptomatic disease. The study may meet FDA requirements for considering the vaccine for emergency-use authorization.

[Copyright 2021 NPR]